Clinical trials

Work at Heights Training: Conventional Approach With and Without Immersive Virtual Reality

Study ID: NCT06728566

Sponsor

Autonomous University of the West

Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease

Study ID: NCT06897566

Sponsor

Cairo University

Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®

Study ID: NCT06504966

Sponsor

Xentria, Inc.

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

Study ID: NCT06525766

Sponsor

Mayo Clinic

Multi-center Screening for Serum M Protein

Study ID: NCT06750965

Sponsor

Zhujiang hospital

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Tumors

Study ID: NCT06202066

Sponsor

Roswell Park Cancer Institute

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients with Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Study ID: NCT06217666

Sponsor

ha o name (Carl) Q IU

A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)

Study ID: NCT06561074

Sponsor

M.D. Anderson Cancer Center

Quantified Evaluation of Noninvasive System Delivering Microwave Energy for Unwanted Fat Reduction and Skin Tightening in Asians.

Study ID: NCT06925074

Sponsor

Chang Chang Cheng

Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA

Study ID: NCT05904626

Sponsor

Elgan Pharma Ltd.